CRISPR-Cas is a new gene editing technique with high target-specificity. It has successful applications in gene knock-out/in/down in many Eukaryota organisms including zebra fish, fruit fly, mouse and monkey. CRISPR-Cas also offers many advantages in manipulating various human cell lines. But I have seen relatively fewer applications in bacteria genetic manipulations and synthetic biology. Does this technique have some limitations in bacterial genome editing? Does CRISPR-Cas have advantages over the traditional genetic tools for bacterial genetics such as homologous recombination?

More Yijie Daniel Deng's questions See All
Similar questions and discussions